Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis
Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis
Not yet recruiting · NCT06590545 · Registry updated 2024-09-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis | Blood-Borne Infections, Genital Diseases, HIV Seropositivity, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, cardiovascular disorder, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, vascular disorder, vasculitis, viral infectious disease, viral sexually transmitted disease | Not yet recruiting | Phase 1 / Phase 2 | 2024-09-19 | NCT06590545 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| David Simon | 1 |
| Kyverna Therapeutics | 8 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||